bibliographic resource 355066 [br/355066]
https://w3id.org/oc/corpus/br/355066
- is a
-
- title
-
- Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase 3 study
- publication date
-
- contributor
-
- format
-
- identifier
-
- part of
-